Literature DB >> 6601861

The significance of antinuclear and DNA antibodies in cryptogenic fibrosing alveolitis.

S T Holgate, P Haslam, M Turner-Warwick.   

Abstract

The roles of antinuclear and DNA antibodies in the pathogenesis of cryptogenic fibrosing alveolitis were investigated in 53 patients. Twenty-two patients who had antinuclear antibodies detected in their serum had a significantly higher proportion of women, a higher prevalence of Raynaud phenomenon and digital vasculitis, and higher erythrocyte sedimentation rates, paralleled by raised serum globulin and IgG levels, than patients with no antinuclear antibodies detected. Serum antibodies to double-strand DNA (DS-DNA), assayed by a Farr binding technique, were significantly raised in 25% of patients with cryptogenic fibrosing alveolitis. Serum binding of single-strand DNA (SS-DNA) was greatly increased in all the patients with cryptogenic fibrosing alveolitis, achieving levels similar to those found in systemic lupus erythematosus. Serum DS-DNA binding correlated with IgA levels but not with disease activity. Thus, unlike in systemic lupus erythematosus, antibodies to DS-DNA and SS-DNA with their capacity to form immune complexes are unlikely to be of major importance in the pathogenesis of cryptogenic fibrosing alveolitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601861      PMCID: PMC459487          DOI: 10.1136/thx.38.1.67

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Antibodies to nucleic acids in myasthenia gravis.

Authors:  M E Gershwin; W Glinski; A N Bender; S P Ringel; A D Steinberg; W K Engel
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

2.  Diffuse pulmonary interstitial disease; an immunohistologic study.

Authors:  H Eisenberg; D H Simmons; E V Barnett
Journal:  Chest       Date:  1979-02       Impact factor: 9.410

3.  Detection of antibodies to DNA: studies using tritiated actinomycin D labelled DNA.

Authors:  B J Young
Journal:  Med Lab Sci       Date:  1976-04

4.  Evaluation of the simultaneous estimation of anti-dsDNA and anti-ssDNA antibodies for clinical purposes.

Authors:  A Lange
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

5.  Assay of circulating immunoglobulins in patients with fibrosing alveolitis.

Authors:  J R Hobbs; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1967-11       Impact factor: 4.330

6.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

Review 7.  Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs.

Authors:  M Turner-Warwick
Journal:  Proc R Soc Med       Date:  1974-06

8.  Specificities of antibodies to native DNA.

Authors:  J J Picazo; E M Tan
Journal:  Scand J Rheumatol Suppl       Date:  1975

Review 9.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects.

Authors:  R G Crystal; J D Fulmer; W C Roberts; M L Moss; B R Line; H Y Reynolds
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

10.  Circulating immune complexes in the idiopathic interstitial pneumonias.

Authors:  R B Dreisin; M I Schwarz; A N Theofilopoulos; R E Stanford
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

View more
  5 in total

1.  Respiration and connective tissue diseases.

Authors:  M J Walport
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

2.  Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?

Authors:  R Meliconi; E Lalli; R M Borzì; C Sturani; V Galavotti; G Gunella; R Miniero; A Facchini; G Gasbarrini
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

3.  Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.

Authors:  R Meliconi; M Bestagno; C Sturani; C Negri; V Galavotti; C Sala; A Facchini; G Ciarrocchi; G Gasbarrini; G C Astaldi Ricotti
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis.

Authors:  A D Kelion; J R Cockcroft; J M Ritter
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

5.  Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  C Robinson; M Callow; S Stevenson; B W Robinson; R A Lake
Journal:  Respir Res       Date:  2001-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.